Please login to the form below

Not currently logged in
Email:
Password:

Matt de Gruchy to lead PR agency Reynolds Mackenzie

He will head up the Open Health agency as its new CEO

Matt de GruchyMatt de Gruchy has joined the Open Health network to head up its PR agency Reynolds Mackenzie.

His new role as chief executive officer will see him drive the firm’s future growth and evolution and will lead its teams in London and Marlow, UK.

De Gruchy will work closely with the agency’s founder Eva Reynolds, who moves into the role of chair.

He said: “I am hugely excited to join the talented team at Reynolds Mackenzie in this exciting time for the agency.

“The RM brand has long been associated with media relations excellence, and is recognised for this by a leading book of clients.

“We must continue with this excellence, but also look to evolve and grow our offer through investment in our digital/social offer and an increasing profile in global comms among other areas.”

De Gruchy joins the agency from Oglivy Healthworld, where he was UK group CEO for the last six years of his 15-year career at the agency.

Sandy Royden, chief executive officer of Open Health, said: “It is fantastic to have someone with Matt’s background and experience come in to lead our team and offer at Reynolds Mackenzie.

“His combined focus on client service excellence and innovating the offer will be invaluable for the next stage of the agency’s journey.”

23rd February 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cegedim Health Data

Cegedim Health Data provides Real World Data and Evidence services to enable advancements in patient outcomes. With a data history...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...